Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
6,010.00    410.00 (7.32%)
Bid:
5,995.00
Ask:
6,005.00
Spread: 10.00 (0.167%)
Market Cap: $1.58t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase

18 Mar 2026 08:28

RNS Number : 1318X
Samsung Electronics Co. Ld
18 March 2026
 

Decision on Share Repurchase

1. Number of shares to be repurchased

Common

37,000,000

Other

-

2. Value of shares to be repurchased (Korean won)

Common

7,174,300,000,000

Other

-

3. Expected repurchase period

Start date

March 19, 2026

End date

June 18, 2026

4. Expected holding period

Start date

-

End date

-

5. Purpose of repurchase

To facilitate employee stock-based compensation

6. Method of repurchase

Open market

7. Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

8. Holding status of treasury shares before repurchase

Repurchase within the allowable distribution profit (shares)

Common

120,813,769

Ratio (%)

2.0

Other

13,603,461

Ratio (%)

1.7

Other repurchase (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

9. Date of board resolution (confirmation date)

March 18, 2026

- Attendance of Independent Directors at the Board of Directors meeting

Present

5

Absent

-

- Attendance of auditors who are not

 Independent Directors

-

10. Daily order quantity limit

Common

8,656,922

Other

-

 

11. Other information to consider:

- Shares denoted as "other" are preferred shares.

- In Item 1 above, number of shares to be purchased was calculated based on the closing price on the day prior to the Board's resolution (March 17, 2026).

(KRW 193,900 per common share)

- The Company plans to acquire treasury shares based on the value of shares to be repurchased in Item 2 above. The actual amount may change depending on future stock price movements.

- With respect to Items 4 and Items 5 above, the Company is repurchasing shares that will be held in treasury for use in stock-based compensation programs, including Performance Stock Units (PSUs; introduced in October 2025) as well as in other programs to incentivize employee performance (e.g., OPI, LTI).

- In Item 9 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 10 above is the smaller of: [] and [the larger of and ].

  10% of the number of shares to be repurchased: 3,700,000 common

  25% of average daily transaction volume over the one month period preceding the date of the board resolution: 8,656,922 common

  1% of total number of issued shares: 59,196,379 common

 

- Limit on the amount of repurchased shares (Korean won)

1. Limits to Dividend eligible profit under Commercial Act as of end-2025

243,066,826,669,885

2. Amount of repurchased shares since end-2025

6,073,607,225,640

3. Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2025

3,753,484,329,311

4. The interim dividend amount and related profit reserves decided by the board of directors since end-2025

-

5. Acquisition cost of the shares in disposing of treasury shares since end-2025

826,550,373,780

Limit on the amount of repurchased shares

(1-2-3-4+5)

234,066,285,488,714

- In Item 1 above, 'Limits to Dividend eligible profit under Commercial Act as of end-2025' is based on the 2025 financial statements approved at the general meeting of shareholders as of the report submission date (March 18, 2026)

-In Item 2 above, 'Amount of repurchased shares since end-2025' represents the book value, including related fees and expenses

 

- Holding status of treasury shares before purchase (number of shares)

* on-market direct purchase

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

36,793,671

7,808,889

-

120,813,769

Other

13,603,461

-

-

-

13,603,461

 

* The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on March 18, 2026, the day the disclosure document was prepared.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMFRRDGVZG
Date   Source Headline
12th May 202110:23 amRNS2020 Business Report
30th Apr 202110:28 amRNS2020 Business Report
30th Apr 202110:13 amRNSChange of the Major Shareholder
29th Apr 202110:41 amRNSCharitable Contribution
29th Apr 202110:38 amRNSCharitable Contribution
29th Apr 202110:34 amRNSCharitable Contribution
29th Apr 202110:33 amRNSTransaction with Affiliate Company
29th Apr 202110:26 amRNSQuarterly Dividend for First Quarter 2021
29th Apr 202110:20 amRNS2021 1Q Earnings Release
7th Apr 20219:12 amRNSNotice of 1Q 2021 Earnings Release Schedule
7th Apr 20219:07 amRNS1Q 2021 Pre-Earnings Guidance
17th Mar 20218:39 amRNSTransaction with Affiliate Company
17th Mar 20218:34 amRNSResults of the 52nd Annual General Meeting
18th Feb 20217:34 amRNS2020 Consolidated Financial Statements
16th Feb 202110:13 amRNSReference Material for 2021 AGM
16th Feb 20219:03 amRNSTransaction with an affiliate
16th Feb 20219:02 amRNSTransaction with an affiliate
16th Feb 20218:31 amRNSCharitable Contribution
28th Jan 202110:29 amRNSShareholder Return Program for FY2021-2023
28th Jan 20219:10 amRNSYear-End Dividend for FY2020
28th Jan 20219:06 amRNS2020 4Q Earnings Release
20th Jan 20219:26 amRNSCourt Judgment Relating to Embezzlement
8th Jan 20217:56 amRNS4Q 2020 Pre-Earnings Guidance
8th Jan 20217:54 amRNSNotice of 4Q 2020 Earnings Release Schedule
1st Dec 20207:00 amRNSCharitable Contribution
1st Dec 20207:00 amRNSCharitable Contribution
30th Nov 202011:26 amRNS2020 3Q Interim Report
30th Nov 20208:51 amRNSTransaction with Affiliate Company
30th Nov 20208:45 amRNSTransaction with Affiliate Company
30th Nov 20208:40 amRNSTransaction with Affiliate Company
30th Nov 20208:39 amRNSTransaction with Affiliate Company
24th Nov 20209:32 amRNSAnnouncement of Investor Relations Event
29th Oct 20208:03 amRNSTransaction with Affiliate Company
29th Oct 20207:53 amRNSAnnouncement of Capex Plan for FY 2020
29th Oct 20207:47 amRNSQuarterly Dividend for Third Quarter 2020
29th Oct 20207:33 amRNS2020 3Q Earnings Release
8th Oct 20209:05 amRNSNotice of 3Q 2020 Earnings Release Schedule
8th Oct 20209:03 amRNS3Q 2020 Pre-Earnings Guidance
7th Sep 20207:00 amRNSSigning of Supply Contract
1st Sep 20207:00 amRNS2020 Half Year Report
30th Jul 20209:02 amRNSTransaction with Affiliate Company
30th Jul 20208:55 amRNSQuarterly Dividend for Second Quarter 2020
30th Jul 20208:42 amRNS2020 2Q Earnings Release
15th Jul 20208:20 amRNSSustainability Report 2020
7th Jul 20208:30 amRNSNotice of 2Q 2020 Earnings Release Schedule
7th Jul 20208:28 amRNS2Q 2020 Pre-Earnings Guidance
29th May 202011:02 amRNS2020 1Q Interim Report
29th May 202010:55 amRNSCorporate Governance Report FY2019
27th May 20209:00 amRNSRenewal of Property & Casualty Insurance Policy
27th May 20208:55 amRNSCharitable Contribution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.